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Abstract
Background: Arteriovenous malformations (AVMs) of the corpus callosum (CC) 
are rare entities. We performed a systematic review of the available literature to 
better define the natural history, patient characteristics, and treatment options for 
these lesions.
Methods: A MEDLINE, Google Scholar, and The Cochrane Library search were 
performed for studies published through June 2015. Data from all eligible studies 
were used to examine epidemiology, natural history, clinical features, treatment 
strategies, and outcomes of patients with CC‑AVMs. A systematic review and 
pooled analysis of the literature were performed.
Results: Our search yielded 37 reports and 230 patients. Mean age at presentation 
was 26.8 years (±13.12 years). AVMs were most commonly located in the 
splenium (43%), followed by the body (31%), and then the genu (23%) of the CC. A 
Spetzler‑Martin grade of III was the most common (37%). One hundred eighty‑seven 
(81.3%) patients presented with hemorrhage, 91 (40%) underwent microsurgical 
excision, and 87 (38%) underwent endovascular embolization. Radiosurgery was 
performed on 57 (25%) patients. Complete obliteration of the AVM was achieved in 102 
(48.1%) patients and approximately twice as often when microsurgery was performed 
alone or in combination with other treatment modalities (94% vs. 49%; P < 0.001). 
Mean modified Rankin Scale ( mRS) at presentation was 1.54 and mean mRS at last 
follow‑up was 1.31. This difference was not statistically significant (P = 0.35).
Conclusion: We present an analysis of the pooled data in the form of a systematic 
review focusing on management of CC‑AVMs. This review aims to provide a 
valuable tool to aid in decision making when dealing with this particular subtype 
of AVM.
Key Words: Arteriovenous malformation, corpus callosum, endovascular therapy
INTRODUCTION
Arteriovenous malformations (AVMs) of the corpus 
callosum (CC) are distinct clinical as well as surgical 
entities. They are known to cause recurrent hemorrhage 
more frequently as compared to more superficial, 
pial AVMs.[18] Optimal treatment of these AVMs is 
controversial not only because they tend to cause mild 
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clinical impairment in the absence of major hemorrhage 
but also because surgical resection may result in 
permanent neurologic deficit as well neuropsychological 
deterioration. In 1951, Basset reported the first successful 
surgical resection of a CC‑AVM.[7] Since surgical 
resection can be technically challenging, less invasive 
therapies have been developed recently for the treatment 
of these lesions. Endovascular treatment has occasionally 
been employed; however, complete obliteration is rarely 
achieved and aggressive embolization can lead to major 
neurological deterioration and possibly treatment‑related 
death. Stereotactic radiosurgery (RS) is a safe and 
effective treatment for select patients with CC‑AVMs as 
it reduces the risk of damage to critical adjacent vascular 
structures. Even large, ruptured AVMs can be treated 
successfully with minimal morbidity and a low risk of 
repeated hemorrhage.[29] Given the paucity of literature 
on CC‑AVMs, the authors aim to delineate the natural 
history, vascular anatomy, treatment approaches, and 
outcomes of this uncommon vascular anomaly.
METHODS
We undertook a review of the literature on CC‑AVMs. 
Our methods were in accordance with the systematic 
review section of the preferred reporting items for 
systematic reviews and meta‑analyses statement.[33] 
Subsequently, a pooled analysis of the literature was 
performed.
Search strategy
Two independent reviewers (Rushna Ali and Aqueel 
H. Pabaney) performed a comprehensive electronic 
search for articles on CC‑AVMs. The search included 
MEDLINE (PubMed and Ovid), Google Scholar, and 
The Cochrane Library from January 1970 to June 2015. 
These databases were queried using keywords and MeSH 
terms “arteriovenous malformation,” “AVM,” “corpus 
callosum,” “radiosurgery,” “endovascular therapy,” 
“microsurgery,” “surgical resection,” and “outcome.” A 
full‑text version was obtained for all studies the reviewers 
considered relevant. To identify additional resources, we 
manually searched references of articles that could be 
potentially relevant. No restrictions were imposed based 
on publication dates, types, or language.
Study selection
We selected articles reporting clinical outcomes for 
patients with CC‑AVMs treated with any of the three 
treatment modalities (i.e., microsurgery, endovascular 
embolization, and RS). We included articles that 
documented patient age, clinical presentation, location 
of AVM, treatment rendered, and outcomes (modified 
Rankin Scale [mRS] or posttreatment complications). 
We included studies not published in English if they 
met the above selection criteria. We excluded articles 
that did not report the location of AVM, treatment 
modality, or outcomes as well as abstracts and letters 
to the editor that were not published as full reports. 
Disagreements between the two reviewers about the 
relevance of a particular study were resolved by discussion 
and consensus with a third reviewer (Ghaus M. Malik or 
Maximillian Kole).
Data extraction
Two independent reviewers (Rushna Ali and Aqueel H. 
Pabaney) performed data extraction. Discrepancies were 
settled by discussion and consensus. Information was 
gathered from eligible articles (systematic review) using 
data abstraction forms, which included the following 
information: Total number of patients, patients’ age and 
gender, location of the AVM within the CC as defined by 
Yasargil’s classification,[52] clinical presentation, treatment 
strategy, obliteration rates, and outcome measures.
Definition of variables
AVM location was divided into those present in the 
genu, body, or splenium of the CC. Presenting symptoms 
were categorized as hemorrhage (i.e., subarachnoid 
[SAH], intraventricular, and intracerebral [ICH]), 
seizures, headaches, and neurological deficits. Others 
were classified as incidental findings. Treatment strategy 
was divided into microsurgical resection, endovascular 
embolization, radiation therapy, or a combination of two 
or more strategies. Obliteration rates were defined as either 
complete obliteration or residual AVM. Long‑term outcome 
was defined by mRS or postoperative complications.
Statistical analysis
We used an independent two‑tailed t‑test (Welch 
generalization of the Student’s t‑test, Microsoft Excel, 
2013, Redmond, WA, USA) to compare preoperative 
and postoperative mRSs. Chi‑square test was utilized 
to compare the difference in AVM obliteration rates 
achieved by various treatment modalities. P value of 0.05 
was considered statistically significant.
RESULTS
Eligibility criteria described in the methods section 
were met by 37 articles, with a total of 230 patients 
[Table 1]. Individual patient data could be obtained 
from 31 reports. All reports were retrospective 
observational cohorts, case reports, and case series. 
No prospective cohorts or randomized studies were 
found.[2‑6,8,10‑12,15‑21,23‑34,37‑42,47,48,50,53,54]
The mean patient age at presentation was 26.82 years 
(±13.12 years; range 2–61 years; median 25 years) with 
a slight male (55%) preponderance. CC‑AVMs were most 
commonly located in the splenium (99 patients; 43%), 
followed by the body (72 patients; 31%), and then the 
genu (54 patients; 23%). Two or more areas of CC were 
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Table 1: Studies reporting patients with corpus callosum arteriovenous malformations
Author and 
year
Number of 
patients
Mean 
age 
(years)
Male: 
female
Presentation Location of 
AVM
S‑M 
grade
Treatment Obliteration 
status*
Mean 
initial 
mRS
Mean 
follow‑up 
mRS
Complications
Akimoto 
2003[2]
1 27 0:1 HA, numbness Splenium, 
body
IV Surgery Complete 1 0 None
Andreussi 
1978[4]
1 13 0:1 HA, LOC Genu II Surgery Complete 5 1 None
Baiz 1964[5] 1 16 0:1 HA, blurred 
vision
Splenium, 
body
IV Surgery Complete 4 0 Foot weakness
Bartal 1970[6] 1 7 1:0 Hemiplegia Genu, body III Surgery Complete 5 3 None
Bendavid 
2004[8]
1 2 0:1 HA Genu III Surgery Complete 1 0 None
Buklina 
2002[10]
36 25 NA Hemorrhage Genu: 9
Body: 7
Splenium: 20
NA Surgery: 29
Observed: 7
NA NA NA NA
Castro‑ 
Caldas 
1989[11]
1 30 0:1 HA Body, 
splenium
IV Surgery Complete 1 0 None
Cone 1979[12] 3 25 2:1 HA, seizures, 
IVH
Genu: 1
Splenium: 2
II: 1
V: 1
NA: 1
Surgery: 1
Observed: 2
Complete 0 0 None
Da Pian 
1980[13]
2 25.5 1:1 SAH Body: 1
Genu: 1
II: 1
III: 1
Surgery Complete 4.5 2 None
Dikel 
et al., 2001[15]
1 6 1:0 HA Holocallosal IV Surgery + 
embolization + 
XRT
NA 1 0 None
Ganapathy 
et al., 2003[16]
1 39 1:0 HA Holocallosal V XRT Complete 1 0 None
Garza‑ 
Mercado 
et al., 1987[17]
1 15 0:1 SAH Holocallosal IV Surgery NA 4 6 Death
Guidetti 
1982[18]
15 35 10:5 SAH: 14
Deficit: 1
Body: 3
Genu: 2
Splenium: 10
NA Surgery: 11;
Observed: 4
Complete: 9
NA: 3
1.87 2.87 Dead: 1
Hemianopsia: 3
Hemiparesis: 1
Memory loss: 1
Herzig 
2000[19]
1 45 0:1 SAH Splenium III XRT Complete 0 0 None
Houtteville 
1989[20]
1 18 0:1 SAH Body II XRT NA 0 1 None
Juhasz 
1978[21]
2 14 0:2 HA Splenium III Surgery Complete 0 1 None
Kohmura 
1990[23]
1 23 1:0 Incidental Splenium III Surgery Incomplete 0 1 None
Kosary 
1978[24]
3 20 2:1 HA Splenium II Surgery: 3 Complete: 2
NA: 1
2 3 Hemianopsia: 1
Death: 1
Koyanagi 
1985[25]
1 NA 1:0 NA Body III Embolization + 
surgery
Complete NA NA NA
Kunc 1974[26] 8 NA NA SAH Genu: 4
Body: 1
Splenium: 2
Holocallosal: 1
NA Surgery, 4 NA NA Excellent: 
3
None
Lobato 
2002[27]
1 58 0:1 SAH Body IV Embolization + 
surgery
Complete 0 0 Memory deficit
Machado 
1984[28]
1 25 0:1 SAH Body and 
splenium
IV Surgery Complete 0 1 None
Contd..
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involved in 13 patients (6%) whereas the entire CC was 
involved in 21 (9%). Spetzler‑Martin grade was reported 
or could be calculated for 135 patients. The most 
common Spetzler‑Martin grade was 3 (51 patients; 37%) 
followed by 2 (38 patients; 28%).
Overall, analysis of 230 patients showed that 187 (81.3%) 
presented with hemorrhage, 5 with focal neurological 
deficit, 10 with seizures without hemorrhage, and 
18 with headaches as the primary symptom. Ninety‑one 
(40%) patients underwent microsurgical resection of the 
AVM. Endovascular embolization was performed either 
as a preoperative adjunct or as a stand‑alone treatment 
modality in 87 (38%) patients. RS was administered to 
57 (25%) patients while two or more treatment modalities 
Table 1: Contd...
Author and 
year
Number of 
patients
Mean 
age 
(years)
Male: 
female
Presentation Location of 
AVM
S‑M 
grade
Treatment Obliteration 
status*
Mean 
initial 
mRS
Mean 
follow‑up 
mRS
Complications
Maruyama 
2005[29]
32 25 15:17 SAH: 28
Other: 4
Genu: 5
Body: 9
Splenium: 19
I: 2
II: 8
III: 17
IV: 4
V: 1
XRT Complete: 21
Incomplete: 11
NA NA Dysarthria: 1
McDonald 
2001[30]
1 47 1:0 Memory 
impairment
Splenium III Embolization + 
XRT
NA: 1 0 0 Memory 
impairment
Milhorat 
1970[31]
1 16 1:0 SAH Body IV Surgery Complete 0 0 None
Mohanty 
2011[32]
1 13 1:0 SAH Body II XRT Complete 0 0 None
Orozco 
2013[34]
2 48.5 1:1 SAH and 
seizure
Body III 
and 
IV
Embolization: 1
Embolization + 
surgery: 1
Complete 
in 1 patient 
undergoing 
surgery
Incomplete: 1
3 2.5 Hemiparesis
Picard 
1996[37]
43 30 25:18 SAH: 36
Seizures: 4
HA: 2
Ataxia: 1
Genu: 11
Body: 6
Splenium: 20
Holocallosal: 9
NA Embolization: 43
XRT: 9
Complete: 8 
(4 embolization, 
4 embolization 
+ XRT)
Incomplete: 35
NA
NA
NA Death: 1
Hemiparesis: 1
Robert 
2015[39]
38 31 17:21 Hemorrhage: 30; 
Incidental: 1; 
Seizures: 4; 
Neuro deficit: 3
Genu: 14
Body: 19
Holocallosal: 5
I: 2
II: 20
III: 9
IV: 6
V: 1
Embolization: 38
XRT: 9
Complete: 22 
(16 embolization, 
6 embolization 
+ XRT)
Incomplete: 10
NA 1.05 Neuro deficit 
NOS: 5
Sell 1997[40] 1 20 0:1 SAH Fornix and 
splenium
III Surgery Incomplete 5 2 Memory 
deficits
Shi 1987[41] 5 25 4:1 SAH Body II: 1
III: 4
Surgery Complete 2 0.8 Seizures; 1
Shimizu 
2001[42]
1 50 1:0 Incidental Body III XRT + 
embolization
Complete 1 0 None
Uchino 
1989[47]
1 16 0:1 SAH Genu and body V XRT Incomplete 2 1 None
Valenstein 
1987[48]
1 39 1:0 SAH Splenium II Surgery Complete 2 2 Memory 
deficits
Wang 
2001[50]
1 51 1:0 SAH Genu and body V Surgery Complete 5 4 Hemiparesis
Yasargil 
1976[54]
8 23.6 5:3 SAH Genu: 5
Body: 6
Holocallosal: 1
III: 1
IV: 4
V: 3
Surgery Complete 1.25 1.1 Hemiparesis: 1
Yasargil 
1976[53]
10 28.2 8:2 SAH: 7
HA: 3
Splenium: 10 III: 6
IV: 2
V: 2
Surgery Complete: 5
NA: 5
0.6 0.7 Hemianopsia: 3
Seizures: 2
*Angiographic obliteration in patients undergoing any treatment modality. NA: Data not available, LOC: Loss of consciousness, HA: Headache, IVH: Intraventricular hemorrhage, 
SAH: Subarachnoid hemorrhage, ICH: Intracranial hemorrhage, XRT: Radiation therapy, S‑M: Spetzler‑Martin, AVM: Arteriovenous malformation, NOS: Not otherwise specified
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were used in combination in 23 (10%). Cumulatively, 212 
(92.1%) patients received treatment whereas 18 (7.8%) 
were managed conservatively. Complete obliteration of 
the AVM was achieved in 102 (48.1%) patients. This was 
accomplished by microsurgery in 44 (43.1%) patients, 
embolization in 20 (19.6%), RS in 24 (23.5%), and 
combination therapy in 14 (13.7%).
Residual AVM was observed in 60 (28.3%) patients. Half 
of these patients underwent stand‑alone embolization 
(30 patients; 50%), 12 (20%) RS alone, and 15 (25%) 
received combination therapy of embolization and 
RS. Of those who underwent surgical resection, only 
3 (5%) patients had a residual nidus. Stand‑alone 
surgical resection or in combination with other treatment 
modalities resulted in complete obliteration in 47 of 
50 (94%) patients whereas only 55 (49%) of 112 who 
underwent embolization alone, RS alone, or combination 
therapy with embolization and RS achieved complete 
obliteration. This difference was found to be statistically 
significant (P < 0.001). Thirty‑two patients encountered 
complications in the immediate posttreatment period; 
however, only 26 patients were left with long‑lasting 
adverse effects from treatment. Three deaths were 
noted in the literature, 2 occurred posttreatment, and 
1 patient died after managed conservatively. Mean mRS 
at presentation was 1.54 and mean mRS at last follow‑up 
was 1.31. The difference between the initial and final 
mRS was not statistically significant (P = 0.35) [Table 2].
DISCUSSION
Epidemiology and natural history
CC‑AVMs are relatively rare. The literature is only 
populated with case series and case reports; hence, the 
natural history of these lesions remains largely unknown. 
The prevalence of CC‑AVMs ranges from 1.1% to 3% in 
population‑based studies[41,42] and from 6.7% to 14.8% 
in hospital‑based cohorts.[1,33,40] Patients with CC‑AVMs 
present at a younger age as compared to patients with 
superficial AVMs. In a report by Buklina, the mean age 
of patients at presentation was 25 years[9] whereas it was 
35 years in a series reported by Guidetti and Spallone.[18] 
CC‑AVMs comprise 8–9% of all intracranial AVMs.[18] 
Since CC‑AVMs are considered deep‑seated lesions, the 
risk of hemorrhage at presentation and subsequent 
rehemorrhage is considered to be higher than superficial 
lesions, mostly by virtue of their location and deep venous 
drainage.[44,45,49] Our literature search yielded 37 reports 
describing 230 patients with CC‑AVMs. Most patients 
harboring CC‑AVMs present with ICH. Examining 
individual reports consisting of multiple patients revealed 
that 70–100% of patients present with ICH or SAH. 
Overall, 187 (81.3%) of 230 patients presented with 
hemorrhage, 10 (4%) presented with seizures without 
hemorrhage, and 18 (7.8%) presented with headache as 
the primary symptom.
Anatomical considerations
CC‑AVMs are generally supplied by the branches of 
the anterior cerebral artery and the posterior cerebral 
artery (PCA) with minor contributions from the middle 
cerebral artery. A recent study indicated that 27 (59%) of 
the 46 nidi studied were supplied by both anterior and 
posterior circulations and 30 (65%) of 46 nidi were fed by 
bilateral pericallosal arteries.[37] Venous drainage generally 
occurs through the superior and inferior sagittal sinuses 
and the galenic system.
Table 2: Patient characteristics with corpus callosum 
arteriovenous malformations
Patient characteristics n
Number of reports 37
Eligible patients 230
Mean age (±SD) years 26.8 (±13.12)
Gender (n=185) (%)
Males 101 (54.5)
Females 84 (45.4)
Presentation (%)
Hemorrhage 187 (81.3)
Seizures 10 (4)
Headache 18 (7.8)
Others 15 (6.5)
Location (%)
Genu 54 (23.4)
Body 72 (31.3)
Splenium 99 (43)
>Two locations 13 (5)
Holocallosal 21 (9.1)
S‑M grade (n=135) (%)
I 4 (2.9)
II 38 (28)
III 51 (37.7)
IV 27 (20)
V 15 (11.1)
Treatment (%)
Surgery 91 (39.5)
Embolization 87 (37.8)
Radiation treatment 57 (24.7)
Combination therapy 23 (10)
Complications (%)
Immediate 32 (13.9)
Long‑term 26 (11.3)
Death 3 (1.3)
Outcomes (mean mRS)
At presentation 1.54
At follow‑up 1.31
S-M: Spetzler-Martin, SD: Standard deviation
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Anatomically, CC‑AVMs can be divided into four main 
groups as described by Yasargil et al.[52‑54] The first group 
includes those lesions that involve the genu and/or 
anterior portion of the CC. Pericallosal arteries are the 
typical feeders for this group of AVMs, with occasional 
contributions from the callosomarginal and anterior 
choroidal arteries. Venous drainage occurs mostly through 
the inferior sagittal sinus via the callosal and septal veins 
or the vein of Galen via internal cerebral veins. The 
second group of CC‑AVMs consists of lesions involving 
the trunk of the CC; these lesions are usually fed by either 
unilateral or bilateral pericallosal arteries. Venous drainage 
occurs via the vein of Galen through the transcallosal 
vein; however, the inferior sagittal sinus may be involved 
as well. The third group consists of AVMs involving 
the posterior third of the body or splenium of the CC. 
These, too, are fed mainly by the pericallosal arteries and 
branches of the PCA including posterior pericallosal and 
posterior choroidal arteries. Venous drainage is mainly 
through the internal cerebral veins and vein of Galen. The 
fourth group consists of holocallosal AVMs, which can 
have variable feeders and drainage patterns. An example 
of a holocallosal AVM is demonstrated in Figure 1.
Picard et al. further divided the AVM nidi into three 
types such as (1) the “compact” nidus, which is well 
demarcated and located within the CC; (2) an “extensive” 
nidus involving the cingulate gyrus or septum pellucidum 
in addition to the CC; and (3) a “diffuse” nidus which is 
ill‑defined and involves various cortical, subcortical, and 
intraventricular regions.[37]
Our analysis reveals that the most common location 
for CC‑AVMs is the splenium. Approximately 10% of 
all CC‑AVMs involve the white matter structure in its 
entirety, and these are the most difficult to treat.
Treatment
Multimodal treatment of complex AVMs is advocated. 
Microsurgical resections aided by endovascular 
embolization and stereotactic RS are the cornerstones of 
therapy for any AVM. Although advances in microsurgery 
have made complete resection of these “inoperable” 
lesions possible, the cure comes with a considerable risk 
of developing new neurological deficits. Endovascular 
embolization rarely achieves complete obliteration of 
the AVM but can significantly aid in occluding feeders 
that are difficult to access early in surgery. Utilization of 
RS for deep‑seated AVMs with nidi measuring <3 cm3 
in volume has increased significantly over the last two 
decades with encouraging results. A more detailed 
discussion of these treatment modalities is as follows.
Surgical resection
Historically, surgical resection of CC‑AVMs has been 
fraught with significant morbidity. However, with 
advanced microsurgical techniques and widespread 
availability of surgical adjuncts such as preoperative 
endovascular embolization and radio surgical 
downgrading, better results are seen in the more recent 
literature. One of the earliest series of surgical resection 
of CC‑AVMs was published by Yasargil et al., in 1976. 
Eighteen patients were treated with microsurgical 
resection without preoperative embolization or 
radiotherapy.[53,54] Of the 18 patients, 15 had presented 
with hemorrhage and all patients belonged to a younger 
age group. A unilateral frontal parasagittal craniotomy 
and interhemispheric approach were employed in all 
cases for AVMs located in the anterior and middle of 
the CC whereas a paramedian parietal or parietooccipital 
craniotomy in sitting position was performed for most 
splenial AVMs. From a technical standpoint, the authors 
considered splenial AVMs to be more challenging 
since most of these were within the substance of the 
splenium and required splitting the splenium along the 
direction of its fibers. No operative mortality or major 
neurological morbidity was encountered. Hemianopsia 
and new onset seizures were the only postoperative 
complications and reported in just a few patients. Buklina 
undertook a complex clinical‑neuropsychological study in 
36 patients who underwent surgical treatment of ruptured 
CC‑AVMs.[9] Preoperative neuropsychological testing 
Figure 1: (a) Axial noncontrast computed tomography scan 
obtained on a young female patient presenting to our institution 
with headaches and altered mental status shows intraventricular 
hemorrhage. (b) Axial computed tomography angiogram 
performed on the same patient reveals an extensive arteriovenous 
malformation involving the entire corpus callosum (holocallosal). 
(c) Lateral projection of internal carotid artery injection reveals a 
large arteriovenous malformation involving the genu, rostrum, and 
body of the corpus callosum. Intranidal aneurysm is also appreciated 
(black arrow). Early venous drainage is seen via galenic system 
(white arrow). (d) Lateral projection of vertebral artery injection 
reveals filling of the splenial component of the arteriovenous 
malformation nidus not seen with internal carotid artery injection 
(white arrow)
ba
dc
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revealed several deficits in all patients such as memory 
impairment, lack of insight, impairment in optical‑spatial 
activity, and partial “split brain” syndrome (i.e., unilateral 
agnosia in different modalities and impairment of 
transferring posture from one side to the other). In 26 of 
29 cases, CC‑AVM was excised via an interhemispheric 
approach. Any postoperative deficits were related to 
the specific area of the CC accessed during surgery. 
After surgery on the anterior portion of the CC, some 
patients showed worsening of frontal dysfunction, with 
increased disinhibition, lack of insight, and impulsivity. 
Split brain syndrome was more commonly observed after 
resection of AVM from intermediate CC whereas patients 
ignored the left edge of the visual field after removal 
of malformations from the posterior portion of the CC 
along with manifestation of split brain syndrome.
Bartal and Yahel argue that the incidence of 
paraventricular lesions, including CC‑AVMs, is 
underestimated and needs more attention as they have 
a higher propensity to bleed and surgical resection could 
result in establishing a definitive cure.[6] They mention 
a case of a young girl in whom the CC‑AVM initially 
bled and then demonstrated significant increase in size 
necessitating treatment. The porencephalic cyst formed 
by prior hemorrhage was thought to be the underlying 
reason for the growth of AVM. Guidetti and Spallone also 
noted that several recurrences of SAH in patients with 
these malformations was not uncommon and strongly 
recommended treatment.[18] Of the 4 patients in their 
series that were managed conservatively, 3 experienced 
recurrent SAH, leading to fatality of 1 patient. Conversely, 
outcomes of 12 patients who underwent surgical resection 
of the AVM were encouraging with minimal neurological 
or psychological deficits. Kosary et al. also reported 
excellent outcomes in 2 of 3 patients with splenial AVMs 
that were treated surgically.[24]
Our pooled analysis of the literature identified fifty 
patients who underwent surgical resection of the 
CC‑AVM with or without prior embolization or RS, and 
cure was achieved in 47 (94%). Only 2 of 46 patients who 
underwent stand‑alone surgical excision of the AVM had 
residual AVM on follow‑up angiogram. Sixteen (32%) 
patients developed permanent complications after surgery, 
and only 1 patient died after surgical intervention.
Endovascular therapy
CC‑AVMs are difficult to treat with endovascular 
therapy alone. The goal of embolization should be 
prevention of hemorrhage and a decrease in nidus 
size to facilitate subsequent surgical resection or 
RS. In 1996, Picard et al. described a series of AVMs 
involving the CC that were treated by endovascular 
means only.[37] They noted the difficulties in treating 
such lesions using endovascular therapy alone, with an 
overall occlusion rate of only 40%. A more recent study 
showed that more than half of the CC‑AVMs in the 
series were completely obliterated using endovascular 
therapy alone, largely due to recent advances in the 
field and the advent of more sophisticated catheters 
and embolization material.[37,39,49] The same study 
also assessed the factors responsible for incomplete 
obliteration and found that holocallosal type, extension 
of the nidus to an eloquent area, nidus size >30 mm, 
and a Spetzler‑Martin grade ≥3 were associated with 
failed endovascular treatment. The complication rate 
associated with these procedures ranges from 5% to 
20%.[37,39,49] Our analysis of the literature revealed 
that fifty patients underwent standalone endovascular 
embolization of the AVM and cure was achieved 
in only 20 (40%), similar to the results noted by 
Picard et al. Only four patients underwent presurgical 
embolization of their AVMs, of which 3 (75%) were 
completely excised. Similarly, 26 patients underwent 
endovascular embolization of the AVM before radiation 
was delivered, but the AVM was completely occluded 
in only 11 (42.3%). Therefore, the authors believe that 
although endovascular intervention is extremely helpful 
in cases of large AVMs with multiple feeders or AVMs 
with deep or inaccessible feeders, complete obliteration 
is rarely achieved and microsurgery or RS must 
supplement embolization to achieve definitive cure.
Radiosurgery
RS is increasingly employed for treatment of small 
(<3 cm3) as well as some medium‑ (3–6 cm) and 
large‑size (>6 cm3) AVMs located in deep cerebral 
tissue. RS is an attractive choice due to its noninvasive 
nature, minimal risk for acute complications, and 
shorter recovery time for the patients. However, cure is 
not immediate and can take 2–3 years for the effects of 
radiation to result in thrombosis of the AVM. Although 
smaller AVMs (<3 cm3) are ideal candidates for RS, 
several reports have confirmed lower obliteration rate 
in larger AVMs.[22,35,36,46,51] Staged RS as well as prior 
embolization to aid in the reduction of radio surgical 
treatment volume has been utilized in the management 
of large AVMs not amenable to surgery.[1,14] Obliteration 
rate varies based on the AVM volume. Obliteration 
rate in AVMs with volumes between 10 and 15 cm3 
has been shown to be approximately 77%, compared to 
25% for those with a volume >15 cm3.[35] Larger AVMs 
also require a longer time for obliteration to occur.[55] 
User‑friendly tools are rapidly becoming available that 
can guide clinicians on likelihood of AVM obliteration 
after RS as well as treatment‑related morbidity. The 
RS‑based grading system and the Virginia RS AVM scale 
were developed recently and consider AVM volume and 
location, patient age, and history of hemorrhage when 
determining a score.[38,43]
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CONCLUSIONS
There is a paucity of available literature on CC‑AVMs. 
The appropriate treatment strategy for these rare lesions 
remains controversial. Through this systematic review of 
literature and analysis of pooled data encompassing almost 
half a century, the authors have attempted to provide a 
tool that will assist healthcare providers to formulate an 
individualized treatment plan for these patients. Although 
microsurgical resection offers the most definitive treatment 
of these lesions, improved outcomes have been observed 
when microsurgery is supplemented with advances in 
RS and endovascular therapy. However, the decision to 
treat a patient with CC‑AVM should weigh the natural 
history of these lesions against potential neurological and 
neuropsychological morbidity that may follow treatment.
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